A Meta-Analysis of Platinum Plus Gemcitabine or Vinorelbine for Advanced Non-small Cell Lung Cancer

@inproceedings{Gao2009AMO,
  title={A Meta-Analysis of Platinum Plus Gemcitabine or Vinorelbine for Advanced Non-small Cell Lung Cancer},
  author={Guanghui Gao and Xinli Zhou and Ruofan Huang and Jingwei Jiang and Zhaohui Chu and Qiong Zhan and Xiaohua Liang},
  year={2009}
}
Background and objective Platinum plus the third-generation agent doublet chemotherapy is the standard regimens and first line chemotherapy for advanced non-small cell lung cancer (NSCLC). The aim of this study is to determine the benefits and harms of platinum plus gemcitabine or vinorelbine for advanced NSCLC. Methods The databases PubMed, CENTRAL, EMBASE and Chinese Biomedical Literature database were retrieved by using the key words "non small cell lung cancer" or "Carcinoma, Non Small… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.